Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Modelling Serous Cancers of the Mullerian Tract using Organoids

FY 2018-19

Summary
Ovarian cancer is the most common gynecologic cancer and the fifth leading cause of cancer death in women. Our study focuses on two subtypes of ovarian cancer: high-grade serous carcinoma (HGSC) of the ovary and low-grade serous carcinoma (LGSC) of the ovary. HGSC is an aggressive type and accounts for up to 70% of all ovarian cancer cases. LGSC is less aggressive, but also much less common (5% of all ovarian cancer cases). Because LGSC is so rare, it is poorly understood. HGSC is often not diagnosed until the cancer is widespread. Treatment for ovarian cancer has not been updated for over 30 years, despite the fact that many women fail therapy to or develop resistance of the drugs. In spite of their differences, HGSC and LGSC are thought to both come from the same type of cells in the Fallopian tube. As a result, we hypothesize that different detrimental changes (mutations) in DNA lead to the initiation and progression of the two distinct subtypes. To model the initiation process, we adopt the novel organoid system wherein we take normal fallopian tube cells and grow them in specialized conditions so that they form 3D structures resembling small organs. We will introduce different mutations specific to HGSC and LGSC into healthy Fallopian tube-organoids and study changes in cells. Cutting-edge sequencing technologies will be utilized to study the changes on a single-cell level. The combination of organoid and single-cell technology well-position us to address the question of how HGSC and LGSC of the ovary occur in the first place. Understanding why and how cancer occur could considerably open up venues for developing early detection and prevention strategies, as well as more targeted therapies for different patients.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
406486
Name
Zhang Joyce (Yu Han)
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Modelling Serous Cancers of the Mullerian Tract using Organoids
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Crispr; Microenvironment Of Tumour; Modelling Tumorigenesis; Organoid (3d Cell Culture System); Ovarian Cancer; Serous Cancer Of The Mullerian Tract
Abstract
Ovarian cancer is the most common gynecologic cancer and the fifth leading cause of cancer death in women. Our study focuses on two subtypes of ovarian cancer: high-grade serous carcinoma (HGSC) of the ovary and low-grade serous carcinoma (LGSC) of the ovary. HGSC is an aggressive type and accounts for up to 70% of all ovarian cancer cases. LGSC is less aggressive, but also much less common (5% of all ovarian cancer cases). Because LGSC is so rare, it is poorly understood. HGSC is often not diagnosed until the cancer is widespread. Treatment for ovarian cancer has not been updated for over 30 years, despite the fact that many women fail therapy to or develop resistance of the drugs. In spite of their differences, HGSC and LGSC are thought to both come from the same type of cells in the Fallopian tube. As a result, we hypothesize that different detrimental changes (mutations) in DNA lead to the initiation and progression of the two distinct subtypes. To model the initiation process, we adopt the novel organoid system wherein we take normal fallopian tube cells and grow them in specialized conditions so that they form 3D structures resembling small organs. We will introduce different mutations specific to HGSC and LGSC into healthy Fallopian tube-organoids and study changes in cells. Cutting-edge sequencing technologies will be utilized to study the changes on a single-cell level. The combination of organoid and single-cell technology well-position us to address the question of how HGSC and LGSC of the ovary occur in the first place. Understanding why and how cancer occur could considerably open up venues for developing early detection and prevention strategies, as well as more targeted therapies for different patients.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zhang, Joyce (Yu Han)
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~